INMD
InMode Ltd.

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

1.43B USD

Market Cap

804.70M USD

Margin of Safety

43.8%

Intrinsic / Market Ratio

1.78×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.12B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

599.95M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.57B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

1.43B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

1.43B USD

from the sum above

Market Cap

804.70M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.78×

the ratio the screener ranks by; Margin of Safety +43.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.12B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)623.99M USD
+②Net Cash Today497.16M USD
+③Growth Value0 USD
=Value1.12B USD

EPV of the Operations (NOPAT over WACC)

623.99M USD

Net cash today

+497.16M USD

Growth Value

0 USD

Value

1.12B USD

①EPV (earnings power value)

623.99M USD

②Net Cash Today

497.16M USD

③Growth Value

0 USD

Market value

Market Cap804.70M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+28.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 599.95M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE516.37M USD
+②Equity at Year 15, Today83.58M USD
=Value599.95M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

516.37M USD

②Equity at Year 15, Today

83.58M USD

Market value

Market Cap804.70M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-34.1%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.57B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.93B USD
+②Invested Capital at Year 15, Today151.39M USD
+③Net Cash Today497.16M USD
=Value2.57B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.93B USD

②Invested Capital at Year 15, Today

151.39M USD

③Net Cash Today

497.16M USD

Market value

Market Cap804.70M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+68.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 16.60%
Cost of Equity =Risk-Free Rate 4.50%+Beta 2.03×Market Risk Premium 6.00%= 16.67%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 16.52M USDPretax Income 110.44M USD= 14.95%

The tax the interest saves.

Interest Expense =EBIT 85.47M USD−Pretax Income 110.44M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 4.46M USDMarket Cap + Total Debt 804.70M USD + 4.46M USD= 0.55%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.45%×Cost of Equity 16.67%+Debt Weight 0.55%×Cost of Debt 4.00%= 16.60%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 721.05M USD − Total Liabilities 91.29M USD = Book Value Today 629.76M USD

Total Debt 4.46M USD − Cash and Short-Term Investments 501.62M USD = Net Debt Today -497.16M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-31.5%at most 5%passes57,544,172 / 83,982,462
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-1.2%at least -10.0%passes(85.34M USD − 93.92M USD) ÷ 721.05M USD
Price to bookMarket Cap ÷ Book Value Today1.28×at most 3×passes804.70M USD ÷ 629.76M USD
Operating marginOperating Income ÷ Revenue23.0%above 10.0%passes85.47M USD ÷ 370.87M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-6.2%above 10.0%does not pass370.87M USD / 395.21M USD
Net cash(Cash − Total Debt) ÷ Market Cap48.7%above -30%passes(396.57M USD − 4.46M USD) ÷ 804.70M USD
Operating efficiencyOperating Income ÷ Gross Profit29.3%above 25.0%passes85.47M USD ÷ 291.26M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

13.98 USD

Enterprise value

326.54M USD

the provider's own figure

EV / EBITDA

4.58×

Price / book

1.31×

the provider's book

Price / earnings

11.55×

Return on equity

12.3%

the provider's figure, not this page's

Profit margin

20.7%

Revenue growth

0.0%

Analyst target, mean

16.19 USD

Analysts

3

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

454.73M492.54M395.21M370.87M

Gross profit

381.17M411.75M317.38M291.26M

Operating income

198.05M195.86M112.64M85.47M

EBITDA

operating income before depreciation and amortisation

198.73M196.48M113.37M86.17M

Pretax income

201.67M217.48M143.61M110.44M

Net income

161.68M198.12M181.46M93.92M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

161.68M198.12M181.46M93.92M

R&D

12.44M13.42M13.15M13.33M
Balance sheet, year end

Total assets

645.05M864.15M786.45M767.20M

Total liabilities

89.88M75.99M81.94M83.31M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

555.17M788.16M704.52M683.88M

Total debt

4.97M9.03M7.83M8.24M

Cash and equivalents

97.64M144.56M155.48M302.85M

Net PP&E

fixed assets after depreciation

7.38M12.09M11.07M10.88M

Working capital

current assets less current liabilities

547.90M781.98M645.25M628.50M
Cash flow

Operating cash flow

181.76M177.00M132.80M85.34M

Capital expenditure

paid out, so below zero

-1.58M-705.70K-669.67K-972.97K

Depreciation and amortisation

680.68K623.62K728.73K695.69K

Free cash flow

operating cash flow plus capital expenditure

180.18M176.30M132.13M84.37M